Twist Bioscience CORP Form 4 insider transactions

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 1,016 shares of common stock to cover tax withholding obligations related to vested performance stock units.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, was awarded 5,633 shares of common stock through performance stock units.

Twist Bioscience Corp's Chief Financial Officer, Adam Laponis, was granted 25,000 shares of common stock through Performance Stock Units after meeting target criteria.

Twist Bioscience's President and COO, Patrick John Finn, reported the acquisition of 79,785 shares of common stock from performance stock units.

Twist Bioscience's Senior Vice President, Chief Legal Officer & Corporate Secretary, Dennis Cho, acquired 29,518 Performance Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience Corp, was awarded 35,513 shares of common stock after performance criteria were met.

Twist Bioscience CEO Emily Leproust acquired 168,976 shares of common stock through the vesting of performance stock units.

Patrick John Finn, President and COO of Twist Bioscience, sold 2,240 shares of common stock at $30.875 per share to satisfy tax withholding obligations from restricted stock unit vesting.

Twist Bioscience CFO Adam Laponis sold shares, including a portion for tax obligations, as disclosed in a recent Form 4 filing.

Twist Bioscience CFO Adam Laponis sold 5,875 shares of common stock to cover tax withholding obligations related to PSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 31,348 shares of common stock at $32.187 per share to cover tax withholding obligations related to PSU vesting.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience, sold 2,041 shares of common stock at $32.187 per share to cover tax withholding obligations.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 9,724 shares of common stock to cover tax withholding obligations related to PSU vesting.

Twist Bioscience's President and COO, Patrick John Finn, sold 23,747 shares of common stock at $32.187 per share to cover tax withholding obligations related to vested Performance Stock Units.

Twist Bioscience Senior VP Dennis Cho sold 3,876 shares of common stock to cover tax withholding obligations related to PSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 476 shares of common stock to cover tax withholding obligations related to Restricted Stock Unit vesting.

Twist Bioscience's Senior VP, Chief Legal Officer & Corporate Secretary, Dennis Cho, sold 124 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 140 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Patrick John Finn, President and COO of Twist Bioscience Corp, sold 206 shares of common stock to cover tax withholding obligations related to Restricted Stock Units.

A Twist Bioscience executive sold 233 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 295 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 1,704 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Twist Bioscience Senior VP Dennis Cho sold 94 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

A Twist Bioscience executive sold 269 shares of common stock at $25.76 per share to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 892 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 2,265 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, reported a planned sale of 235 shares of common stock to cover tax withholding obligations.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 853 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 2,716 shares of common stock at $25.964 per share to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 238 shares of common stock to cover tax withholding obligations related to RSU vesting.